Myomo (MYO) Change in Receivables (2016 - 2025)
Myomo's (MYO) quarterly Change in Receivables came in at -$1.9 million in Q3 2025, down 283.81% on a YoY basis from $1.0 million in Q3 2024, and down 179.72% quarter-over-quarter from $2.3 million in Q2 2025.
Analysis
Myomo (MYO) Change in Receivables (2016 - 2025) Analysis & Trends
Myomo (MYO) has reported Change in Receivables for 10 consecutive years, with -$1.9 million the latest figure, recorded in Q3 2025.
- For the quarter ending Q3 2025, Change in Receivables fell 283.81% year-over-year to -$1.9 million; the trailing twelve-month figure through Sep 2025 stood at $1.6 million (up 57.6% YoY), and the FY2024 full-year result was $1.6 million, up 214.69% from the prior year.
- Change in Receivables retreated to -$1.9 million in Q3 2025 per MYO's latest filing, from $2.3 million in the prior quarter.
- Across five years, Change in Receivables topped out at $2.3 million in Q2 2025 and bottomed at -$1.9 million in Q3 2025.
- Historically, Change in Receivables has averaged $219224.1 across 5 years, with a median of $239274.0 in 2022.
- The sharpest annual moves came in 2021 and 2025: Change in Receivables soared 6143.87% in 2021, then plunged 283.81% in 2025.
- Over 5 years, Change in Receivables stood at -$235707.0 in 2021, then soared by 233.77% to $315314.0 in 2022, then tumbled by 141.23% to -$129997.0 in 2023, then surged by 440.97% to $443252.0 in 2024, then sank by 520.54% to -$1.9 million in 2025.
- According to Business Quant data, Change in Receivables over the past three periods registered -$1.9 million, $2.3 million, and $637054.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 74.90 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | -224.00 Mn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 177.00 Mn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 46.00 Mn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 10.20 Mn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | - |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 172.10 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | -90.00 Mn |
| 10 | Myomo | 54.96 Mn | 35.99 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -1.86 Mn |
| Jun 30, 2025 | 2.34 Mn |
| Mar 31, 2025 | 637,054.00 |
| Dec 31, 2024 | 443,252.00 |
| Sep 30, 2024 | 1.01 Mn |
| Jun 30, 2024 | 820,910.00 |
| Mar 31, 2024 | -718,676.00 |
| Dec 31, 2023 | -129,997.00 |
| Sep 30, 2023 | 861,473.00 |
| Jun 30, 2023 | 104,656.00 |
| Mar 31, 2023 | -340,533.00 |
| Dec 31, 2022 | 315,314.00 |
| Sep 30, 2022 | 239,274.00 |
| Jun 30, 2022 | -329,285.00 |
| Mar 31, 2022 | -272,748.00 |
| Dec 31, 2021 | -235,707.00 |
| Sep 30, 2021 | 1.09 Mn |
| Jun 30, 2021 | 364,097.00 |
| Mar 31, 2021 | -169,642.00 |
| Dec 31, 2020 | 608,869.00 |